PDF-Developing Long-Acting Injectables
Author : genevieve | Published Date : 2021-01-05
delivering the ng technologies rapeutics by the potentials e Dr Joël Richard is currently Head of Technical Pharmaceutical Operations at MedinCell Montpellier
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Developing Long-Acting Injectables" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Developing Long-Acting Injectables: Transcript
delivering the ng technologies rapeutics by the potentials e Dr Joël Richard is currently Head of Technical Pharmaceutical Operations at MedinCell Montpellier France He is leading all the ph. Study acting where films are made. Film Acting Bay Area offers film acting classes of all levels. Classes are taught by actors, directors and producers in the San Francisco Bay Area. David Hubacher, PhD. Senior Epidemiologist. FHI. Outline of Talk. Description of long-acting reversible contraception (LARC). Worldwide use of long-acting. Advantages and Disadvantages. Service delivery factors. Anxiolytics. :. Benzodiazepines & others. Tracy A. Womble, . Ph.D. Florida A&M University . College of Pharmacy and Pharmaceutical Sciences. SEDATIVE-HYPNOTICS . History of Sedatives. Alcohol, the oldest known sedative. PrEP. Anton Pozniak . MD FRCP. Consultant Physician . . Disclosures. I have received honoraria, travel sponsorship and research grants from:. Gilead Sciences . Janssen. MSD. ViiV Healthcare. BUT… success depends on adherence.. for PrEP. Sinead Delany-Moretlwe. University of the Witwatersrand. IAS, Amsterdam, July 2018. Women account for more than half of adults living with HIV globally. Young women are twice as likely to be living with HIV as young men. bronchodilators include Combiventum Take with Respimatium Take with nebulizer These medications are long-acting Long-acting bronchodilators are used regularly to open the airways and keep them open Lo What it is. Contains progesterone . Depo-Provera is the most widely used injectable contraceptive . Injection given every 3 months. 2. Mechanism of Action. 3. Thickens . cervical mucus to block sperm. Shelly Malhotra,. Senior Director, Global Access, IAVI. No conflicts of interest are declared. Co-authors. S. Malhotra, M. Keane, A. Kurzman, N. Sender, M. Price, IAVI, New York, United States. Evolving Access Pathways for Long-Acting HIV Prevention Products. PrEP. Against Vaginal SHIV Transmission in Macaques. Elena Bekerman*, . Derek Hansen, Bing Lu, Kelly Wang, William Rowe, . Federico Campigotto, Jim Zheng, Moupali Das, Christian Callebaut, Stephen R. Yant. JNMC, AMU. Management of Bronchial Asthma. Introduction. . Asthma is a . chronic inflammatory disorder . of the airways that is . characterized:. clinically. . by. recurrent episodes of wheezing, breathlessness, chest tightness, and cough, particularly at night / early morning. . Presented by Carol Nati MD, MS, DFAPA. Medical Director, MHMR of Tarrant County. Overview. Long Acting Injectable Antipsychotic Medications are underutilized in Texas.. They have been proven to work well.. Dr Rebecca Bowen. Medical Oncologist Breast and Gynae Cancers. Royal United Hospitals Bath NHS Foundation Trust. Audit performed by Dr Georgina Casswell and Dr Georgina . Gullick. Background. P. rimary GCSF is used in breast cancer chemotherapy regimens to reduce rates of febrile neutropenia . Constance A. Benson, MD. Professor of Medicine and Global Public Health. University of California San Diego. La Jolla, California. Goals for the Workshop. To describe the potential benefits of long-acting antiretroviral drugs (ARVs) for treatment and prevention of HIV infection. Metformin . monotherapy. a. HbA1c <6.5%. Continue current therapy. HbA1c ≥ 6.5-8.5 %. Maximize . metformin. a. 2. Add 2. nd. tier . agent. b. HbA1c ≥10%. d. Maximize . metformin. a. Add 2. nd.
Download Document
Here is the link to download the presentation.
"Developing Long-Acting Injectables"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents